Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Autoantibodies: The Predictive and Pathogenic Role of Pro-Inflammatory Cytokines in Type 1 Diabetes.

Iranian journal of immunology : IJI·2026
Same author

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

BioMed research international·2026
Same author

Targeting mtDNA to Modulate Mitochondrial Dysfunction in Neurodegenerative Diseases.

Molecular neurobiology·2026
Same author

Micro- and nanoencapsulation strategies for mefenamic acid delivery: carrier design, release mechanisms, and preclinical performance.

Journal of microencapsulation·2026
Same author

18-β-Glycyrrhetinic-loaded poly(lactic-co-glycolic) (PLGA) nanoparticles downregulate the expression LPS-induced proteins mediating tissue remodelling in vitro.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same author

Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review.

Inflammopharmacology·2026

Related Experiment Video

Updated: Aug 18, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

437

Luteolin: a flavonoid with a multifaceted anticancer potential.

Parteek Prasher1, Mousmee Sharma2, Sachin Kumar Singh3,4

  • 1Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.

Cancer Cell International
|December 9, 2022
PubMed
Summary

Luteolin, a plant-derived polyphenol, shows significant anticancer potential by targeting key cancer pathways. Its ability to induce oxidative stress and apoptosis offers a promising, physiologically benevolent alternative to traditional chemotherapy.

More Related Videos

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.0K
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.4K

Related Experiment Videos

Last Updated: Aug 18, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

437
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.0K
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.4K

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Oncology

Background:

  • Polyphenolic phytochemicals, like luteolin, are recognized for therapeutic effects in traditional medicine.
  • Luteolin, a flavone, exhibits antioxidant and pro-oxidant properties, suggesting potential in managing hypertension, inflammation, and cancer.
  • The limitations of conventional chemotherapy necessitate the search for safer, effective anticancer agents.

Purpose of the Study:

  • To review the anticancer profile of luteolin.
  • To explore luteolin's mechanisms of action against cancer cells.
  • To highlight luteolin as a potential physiologically benevolent anticancer agent.

Main Methods:

  • Literature review of studies investigating luteolin's effects on cancer.
  • Analysis of research on luteolin's molecular targets and pathways involved in oncogenesis.
  • Examination of data on luteolin's impact on cancer cell proliferation, apoptosis, and angiogenesis.

Main Results:

  • Luteolin demonstrates anticancer activity through multiple mechanisms.
  • It downregulates key oncogenic pathways and inhibits cancer cell proliferation and angiogenesis.
  • Luteolin induces oxidative stress and cell cycle arrest, promoting apoptosis in cancer cells.

Conclusions:

  • Luteolin possesses a significant anticancer profile with potential therapeutic applications.
  • Its multifaceted action makes it a promising candidate for developing novel, safer cancer treatments.
  • Further research into luteolin could lead to the identification of effective anticancer molecules.